When and how to use informatics tools in caring for urologic patients

Nature Clinical Practice Urology

Volumn 2, Issue 4, 2005, Pages 183-190

  Kattan, Michael W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Decision making; Nomograms; Prediction tools

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; BRACHYTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER MODEL; COMPUTER PROGRAM; CONFIDENCE INTERVAL; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; ENTEROPATHY; HIGH RISK PATIENT; HUMAN; IMPOTENCE; INCONTINENCE; INFORMED CONSENT; MEDICAL DECISION MAKING; MEDICAL INFORMATICS; METASTASIS; NOMOGRAM; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; URINARY TRACT DISEASE; VALIDATION PROCESS;

HUMANS; THERAPY, COMPUTER-ASSISTED; UROLOGIC DISEASES;

EID: 20444477600     PISSN: 17434270     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpuro0144     Document Type: Review

References (26)

1. Miles BJ et al. (1999) Recall and attitudes in patients with prostate cancer. Urology 53: 169-174
2. Clark JA et al. (2001) Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer. J Clin Oncol 19: 72-80
3. Kattan MW and Scardino PT (2002) Prediction of progression: nomograms of clinical utility. Clin Prostate Cancer 1: 90-96
4. Fowler FJ Jr et al. (2000) Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 283: 3217-3222
5. Kattan MW (2003) Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol 13: 111-116
6. Yanke BW et al. (2005) Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J Urol 173: 421-424
7. Ohori M et al. (2004) Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J Urol 171: 1844-1849
8. Partin AW et al. (2001) Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58: 843-848
9. Koh H et al. (2003) A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. J Urol 170: 1203-1208
10. Cagiannos I et al. (2003) A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 170: 1798-1803
11. Kattan MW et al. (2003) Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 170: 1792-1797
12. Kattan MW et al. (1998) A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90: 766-771
13. Graefen M et al. (2002) International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol 20: 3206-3212
14. Bianco FJ Jr et al. (2003) Radical prostatectomy nomograms in black American men: accuracy and applicability. J Urol 170: 73-77
15. Greene KL et al. (2004) Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (CAPSURE). J Urol 171: 2255-2259
16. Graefen M et al. (2002) A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men. Urol Oncol 7: 141-146
17. Ross PL et al. (2002) Comparisons of nomograms and urologists' predictions in prostate cancer. Semin Urol Oncol 20: 82-88
18. Eastham JA et al. (2003) Cancer and Leukemia Group B (CALGB) 90203: A randomized phase III study of radical prostatectomy alone versus estramustine and docetaxel prior to radical prostatectomy for patients with high-risk localized disease. Urology 62 (Suppl 1): S55-S62
19. Kattan MW et al. (2000) Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol 18: 3352-3359
20. Kattan MW et al. (2003) Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. J Clin Oncol 21: 4568-4571
21. Kattan MW et al. (2001) Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology 58: 393-399
22. Kattan MW et al. (1999) Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17: 1499-1507
23. Graefen M et al. (2002) A validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol 20: 951-956
24. Dotan Z et al.: The pattern of PSA failure dictates the probability of a positive bone scan in patients PSA after radical prostatectomy. J Clin Oncol, in press
25. Smaletz O et al. (2002) A nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol 20: 3972-3982
26. Halabi S et al. (2003) Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. J Clin Oncol 21: 1232-1237